Research & Development



  雲瑯看看興奮地曹襄苦笑道︰“征發三十萬將士,然後再攜帶二十萬民夫,準備五百萬擔以上的軍糧,在帶上不少于三十萬頭牲畜,說不定就能去一趟大宛國,取回天馬。”   當這個賢明的人開始質疑伊秩斜成為單于的可能性的時候,在場的匈奴人全部沉默了,如果伊秩斜不能給出一個讓所有人都滿意的答案,他今天將死無葬身之地!免播放器的H网站   充滿欲望的伊秩斜這時候需要幫助,需要一個能隨時告訴他軍臣單于病情的人。骑姐姐新站   霍去病淡淡的道︰“殺干淨就一了百了了。”   軍臣單于看著兒子離開了,有些欣慰,撫摸著胸口笑道︰“好孩子……伊秩斜,你知……”精品国产自在线拍   一個滿是皺褶,蒼老的手死死的掐住她的脖子,只見屠耆王憤怒的沖著她吼道︰“你這個妖婦!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo